Operating Lease, Liability, Noncurrent in USD of Vitro Biopharma, Inc. from Q3 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Vitro Biopharma, Inc. quarterly Operating Lease, Liability, Noncurrent history and change rate from Q3 2022 to Q2 2025.
  • Vitro Biopharma, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 31 Jul 2025 was $144K, a 43.8% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $144K -$112K -43.8% 31 Jul 2025 10-Q 12 Sep 2025
Q1 2025 $171K -$114K -40.1% 30 Apr 2025 10-Q 20 Jun 2025
Q4 2024 $198K -$117K -37.1% 31 Jan 2025 10-Q 20 Mar 2025
Q3 2024 $227K -$119K -34.5% 31 Oct 2024 10-Q 12 Sep 2025
Q2 2024 $256K -$129K -33.6% 31 Jul 2024 10-Q 16 Sep 2024
Q1 2024 $285K +$80.9K +39.6% 30 Apr 2024 10-Q 31 May 2024
Q4 2023 $315K +$99.6K +46.2% 31 Jan 2024 10-Q 14 Mar 2024
Q3 2023 $346K +$119K +52.2% 31 Oct 2023 10-K 28 Jan 2025
Q2 2023 $385K 31 Jul 2023 10-Q 28 Aug 2023
Q1 2023 $204K 30 Apr 2023 10-Q 13 Jun 2023
Q4 2022 $216K 31 Jan 2023 10-Q 14 Mar 2023
Q3 2022 $227K 31 Oct 2022 10-K 29 Jan 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.